Enovix Corporation ENVX Weighted Average Exercise Price of Vested and Expected to Vest Options

Weighted Average Exercise Price of Vested and Expected to Vest Options at other companies

BillionToOne, Inc. BLLN

$14.61—

Lantheus HoldingsLNTH

$69.07—

HTF

Heartflow, Inc. Common StockHTFL

9.9—

Esperion TherapeuticsESPR

$5.06-22.9%

ArdelyxARDX

$5.54-1.6%

Oruka Therapeutics, Inc.ORKA

$18.66+56.0%

Other financials

Income statement

See full

Revenue$7.6M+49.1%

Gross profit$1.6M+495%

Operating income-$43.9M-3.1%

Net income-$38.3M-62.7%

EPS (diluted)-$0.18-50.0%

Balance sheet

See full

Cash & equivalents$90.6M-52.7%

Total debt$543.6M+179%

Total equity$240.7M+2.4%

Total assets$833.9M+67.1%

Cash flow

See full

Operating cash flow-$33.1M-95.6%

CapEx$3.2M-48.7%

Free cash flow-$36.3M-56.6%

Valuation

See full

Market cap$1.3B-18.0%

Enterprise value$1.75B+10.5%

P/S37.8×-31.2×

Profitability

See full

Gross margin21.5%—

Operating margin-520.3%-160pp

Net margin-499.6%-149pp

FCF margin-368.9%-117pp

Returns & leverage

See full

Return on equity-72.1%-10.0pp

Debt / equity2.3×+1.4×

Current ratio11×+6.3×

Where this comes from

Reported directly by Enovix Corporation in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice.

The official record: Enovix Corporation’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Enovix Corporation's weighted average exercise price of vested and expected to vest options.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Enovix Corporation's weighted average exercise price of vested and expected to vest options?: Enovix Corporation (ENVX) reported weighted average exercise price of vested and expected to vest options of $9.72 in Q1 2026.